(Updates with comment from study author Charles Harding throughout story.) By Reuters Staff (Reuters Health) - Breast cancer screenings may not lead to fewer deaths but may lead to overdiagnosis, U.S. researchers suggest. In areas of the U.S. with high levels of screening, more tumors were diagnosed - but breast cancer death rates were no lower than in areas with fewer screenings, researchers report.